34
Participants
Start Date
May 24, 2022
Primary Completion Date
December 30, 2027
Study Completion Date
December 30, 2027
Venetoclax 100 mg d1，200 mg d2，400 mg d3-14；
VHEA -Induction Phase Regimen/Consolidation therapy after remission
RECRUITING
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University（Huai'an First People's Hospital）, Huai'an
Zhenjiang First People's Hospital
OTHER
The First People's Hospital of Changzhou
OTHER
The Affiliated Hospital of Xuzhou Medical University
OTHER
Huai'an First People's Hospital
OTHER